ReviewBrain pathology (Zurich, Switzerland)1998
Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline.
Review in Brain pathology (Zurich, Switzerland), 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 103 citations in OpenAlex.
- Diagnosis and Management of Progressive Corticobasal Syndrome.Current treatment options in neurology · 2024Article
- Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies.Seminars in nuclear medicine · 2021Review
- Chinese nutraceuticals and physical activity; their role in neurodegenerative tauopathies.Chinese medicine · 2021Review
- Corticobasal degeneration and corticobasal syndrome: A review.Clinical parkinsonism & related disorders · 2019Review
- Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.Neurochemical research · 2015Article
- Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias.Alzheimer's research & therapy · 2014Review
- Corticobasal degeneration: a pathologically distinct 4R tauopathy.Nature reviews. Neurology · 2011Review
- Voxel-based morphometry in autopsy proven PSP and CBD.Neurobiology of aging · 2008Article
- Neural correlates of caregiver burden in cortical basal syndrome and frontotemporal dementia.Dementia and geriatric cognitive disorders · 2008Article
- Progressive supranuclear palsy: pathology and genetics.Brain pathology (Zurich, Switzerland) · 2007Review
- Signature tau neuropathology in gray and white matter of corticobasal degeneration.The American journal of pathology · 2002Article
- Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature.Journal of neurology, neurosurgery, and psychiatry · 2000Article
- Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease.Brain pathology (Zurich, Switzerland) · 1999Review
- Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.Journal of neurology · 1999Review
- The tauopathies: toward an experimental animal model.The American journal of pathology · 1999Review
- Establishing a pathological diagnosis in degenerative dementias.Brain pathology (Zurich, Switzerland) · 1998Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Corticobasal ganglionic degeneration (CBGD) and progressive supranuclear palsy (PSP) were originally described in the sixties as predominantly motor syndromes. Over the years, the detailed study of additional cases of CBGD has shown that it is a distinctive histological entity which can often present as dementia or aphasia. Although some pathological features of CBGD overlap with those of other forms of non-Alzheimer non-Lewy body dementia, the distribution and relative number of these abnormalities and the distinctive pattern of tau immunodeposits allows the distinction of CBGD from Pick's disease and fronto-temporal dementia. In contrast, PSP only rarely presents with prominent dementia or behavioral changes. In these unusual PSP cases, care must be taken to exclude the diagnoses of CBGD and familial tangle-only dementia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.